Lilly 3270 Pill — GREEN;BLUE CAPSULE, 20mm — Duloxetine

No photo available
View full Duloxetine profile
ImprintLilly / 3270
ColourGREEN;BLUE
ShapeCAPSULE
Size20
StrengthDuloxetine hydrochloride 60 mg
Dosage formCapsule, Delayed Release
ManufacturerCarilion Materials Management
NDC68151-4727
Schedule—
Availability—
IngredientsDuloxetine hydrochloride[Duloxetine]

What does this imprint mean?

The imprint "Lilly 3270" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Duloxetine

Uses and warnings

BOXED WARNING: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is essential during treatment initiation and dose changes. Key Precautions Include: - Hepatotoxicity: Risk of liver failure; avoid in chronic liver disease or cirrhosis - Orthostatic Hypotension & Falls: May cause blood pressure drops and syncope, particularly in elderly patients - Serotonin Syndrome: Dangerous interaction risk with MAOIs and other serotonergic drugs - Abnormal Bleeding: Increased bleeding risk, especially with NSAIDs or anticoagulants - Discontinuation Symptoms: Gradual dose reduction recommended to avoid dizziness, headache, nausea - Severe Skin Reactions: Stevens-Johnson Syndrome possible; discontinue at first sign - Angle-Closure Glaucoma: May trigger attacks in susceptible patients - Blood Pressure Monitoring: Required before and during treatment ---

Duloxetine delayed-release capsules are indicated for treating: "Major Depressive Disorder (MDD)," "Generalized Anxiety Disorder (GAD)," "Diabetic Peripheral Neuropathy," and "Chronic Musculoskeletal Pain." ---

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Duloxetine

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 9a379a19-a042-42b5-a8b3-52a0f384de06.xml